The impact of participation in a study of medical treatment of lower urinary tract symptoms on the incidence of prostate surgery.
Is the incidence of prostate surgery influenced by participation in a study of medical treatment of lower urinary tract symptoms (LUTS)? In order to research the possible answers to this question, we established a retrospective, observational study of the 127 patients from Norway who participated in the Scandinavian Reduction of the Prostate Study (SCARP), which was a multicenter, double-blind, placebo-controlled 2-year study to assess the clinical efficacy of 5 mg finasteride in patients with an enlarged prostate and moderate LUTS. In the present study, the ten Norwegian urologists who were involved in SCARP, performed a chart review and recorded all cases of prostate surgery that had taken place during the 2-year SCARP period and the year following SCARP. The incidence of prostate surgery was 19.8 per 1,000 person-years during the SCARP period, versus 127 per 1,000 person-years the following year (P < 0.001). Among the Norwegian participants in SCARP, prostate surgery was performed more frequently after completion of SCARP. Several possible explanations are discussed.